Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
3.
N Engl J Med ; 369(18): 1704-1714, 2013 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-24131138

RESUMEN

BACKGROUND: Deep dermatophytosis is a severe and sometimes life-threatening fungal infection caused by dermatophytes. It is characterized by extensive dermal and subcutaneous tissue invasion and by frequent dissemination to the lymph nodes and, occasionally, the central nervous system. The condition is different from common superficial dermatophyte infection and has been reported in patients with no known immunodeficiency. Patients are mostly from North African, consanguineous, multiplex families, which strongly suggests a mendelian genetic cause. METHODS: We studied the clinical features of deep dermatophytosis in 17 patients with no known immunodeficiency from eight unrelated Tunisian, Algerian, and Moroccan families. Because CARD9 (caspase recruitment domain-containing protein 9) deficiency has been reported in an Iranian family with invasive fungal infections, we also sequenced CARD9 in the patients. RESULTS: Four patients died, at 28, 29, 37, and 39 years of age, with clinically active deep dermatophytosis. No other severe infections, fungal or otherwise, were reported in the surviving patients, who ranged in age from 37 to 75 years. The 15 Algerian and Tunisian patients, from seven unrelated families, had a homozygous Q289X CARD9 allele, due to a founder effect. The 2 Moroccan siblings were homozygous for the R101C CARD9 allele. Both alleles are rare deleterious variants. The familial segregation of these alleles was consistent with autosomal recessive inheritance and complete clinical penetrance. CONCLUSIONS: All the patients with deep dermatophytosis had autosomal recessive CARD9 deficiency. Deep dermatophytosis appears to be an important clinical manifestation of CARD9 deficiency. (Funded by Agence Nationale pour la Recherche and others.).


Asunto(s)
Proteínas Adaptadoras de Señalización CARD/deficiencia , Proteínas Adaptadoras de Señalización CARD/genética , Tiña/genética , Adulto , África del Norte , Anciano , Anciano de 80 o más Años , Proteínas Adaptadoras de Señalización CARD/metabolismo , Femenino , Efecto Fundador , Genes Recesivos , Homocigoto , Humanos , Interleucina-6/metabolismo , Masculino , Persona de Mediana Edad , Mutación , Linaje , Tiña/patología
6.
J Dermatolog Treat ; 19(2): 72-81, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18484426

RESUMEN

This review outlines recent data on treatment modalities and outcomes with antifungal therapy in onychomycosis. Included are topical, mechanical, chemical and systemic treatments or a combination thereof. Topical treatments, or transungual drug delivery systems (TUDDS), including ciclopirox and amorolfine were shown to be effective if used alone for mild-moderate nail involvement. Specifically, superficial white onychomycosis (SWO) restricted to the dorsum of the nail plate and moderate distal lateral subungual onychomycosis (DLSO). Mechanical treatments were mostly effective as adjuncts to topical therapy which include nail avulsion and abrasion. In particular, partial nail avulsion aids topical therapy in DLSO and partial subungual onychomycosis for a more effective therapy. Chemical avulsion is a painless method of debridement which uses a keratinolysis formula that is effective only in limited and early disease. Systemic therapies have been shown to be effective with terbinafine and itraconazole is suggested as being the most cost-effective therapy. Systemic therapies require consideration of side effects and monitoring by both patient and physician prior to treatment application. An effective suggestion is the use of a topical with debridement for mild-moderate onychomycosis and systemic (terbinafine) plus topical for severe onychomycosis. Most treatment modalities will require long-term use from 3 to 9 months to be most effective, with strategies presented in Part II of this review.


Asunto(s)
Antifúngicos/uso terapéutico , Onicomicosis/tratamiento farmacológico , Onicomicosis/cirugía , Antifúngicos/administración & dosificación , Humanos , Onicomicosis/diagnóstico , Índice de Severidad de la Enfermedad
7.
Am J Trop Med Hyg ; 74(3): 500-4, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16525113

RESUMEN

Severity of lymphedema and presence of entry lesions are risk factors for acute bacterial dermatolym-phangioadenitis (ADLA) in those with filarial lymphedema. Recurrent ADLA causes acute morbidity and progression of lymphedema severity; however, there is little work assessing the ability of health workers to reliably stage disease severity and identify risk entry lesions. This knowledge is important in initiation of management and assessing interventions. We evaluated inter-rater reliability with two independent health workers rating both legs of 17 patients using a questionnaire and the Dreyer classification of lymphedema. The health workers could reliably stage lymphedema with high agreement (RMAC weighted kappa of 0.89) and identify nail, interdigital, and other skin lesions. However, there was less consistency in identifying the clinical nature of skin lesions. This indicates that the Dreyer classification can be a replicable way to stage lymphedema and a questionnaire can deliver high observer agreement on the presence of risk lesions.


Asunto(s)
Filarioidea/crecimiento & desarrollo , Linfedema/diagnóstico , Linfedema/parasitología , Animales , Personal de Salud/normas , Humanos , Variaciones Dependientes del Observador
9.
Curr Opin Infect Dis ; 21(2): 119-21, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18317032

RESUMEN

This article examines the reasons for clusters of cases or outbreaks of sporotrichosis such as the Brazilian outbreak described in this issue of Current Opinion in Infectious Diseases. It highlights areas that require elucidation such as the infectivity of yeast phase fungi in relation to other outbreaks. It then describes phenotypic variations seen with Sporothrix schenckii that could contribute to pathogenesis and enhanced infectivity of fungi in the environment.


Asunto(s)
Brotes de Enfermedades , Sporothrix/patogenicidad , Esporotricosis/microbiología , Animales , Brasil/epidemiología , Enfermedades de los Gatos/microbiología , Enfermedades de los Gatos/transmisión , Gatos , Enfermedades Endémicas , Exposición a Riesgos Ambientales/efectos adversos , Humanos , Sporothrix/clasificación , Esporotricosis/epidemiología , Esporotricosis/transmisión , Virulencia , Zoonosis/microbiología , Zoonosis/transmisión
10.
J Dermatolog Treat ; 19(3): 168-75, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18569273

RESUMEN

This portion of the antifungal review focuses on treatment rationale and suggestions, including special populations such as the elderly, children, and pregnant and immunocompromised individuals. In elderly individuals, the pathogen may be associated with certain comorbidities; treatment should begin with local treatments such as debridement (mechanical or chemical) and a topical. In children, the pathogen most commonly isolated is Trichophyton rubrum. Children should be examined for concomitant tinea and treatment options can begin with a chemical debridement (non-painful) and a topical, with non-responders being treated with combination therapy as in adults. It is suggested that blood tests are monitored at baseline and every 4-8 weeks in children on systemic therapy. Terbinafine is the only systemic in category B and local therapies should be the primary treatment modalities in pregnancy. Prevalence of onychomycosis is high in immunocompromised patients with higher relapse rates after treatment. The same fungal infections that are seen in healthy populations are usually represented in the immunocompromised host. There is a stepwise approach that is suggested in the treatment of onychomycosis. Before treatment, several factors should be determined, which include risk for failure and compliance issues. Strategies for therapy include monotherapy, combination therapy, supplemental therapy, and intermittent therapy. Topical monotherapy is effective in early distal nail disease and for the prevention of reinfection of the cured nail. Combination therapy is an appropriate progression of therapy for patients who failed monotherapy or are at risk for failure. Combined therapies are shown to increase cure rates. Mechanical interventions are essential in reducing fungal burdens to allow other modalities to penetrate, especially in dermatophytomas and onycholysis.


Asunto(s)
Antifúngicos/administración & dosificación , Arthrodermataceae , Onicomicosis/tratamiento farmacológico , Adulto , Anciano , Niño , Desbridamiento , Quimioterapia Combinada , Femenino , Humanos , Huésped Inmunocomprometido , Hongos Mitospóricos , Uñas/cirugía , Onicomicosis/inmunología , Onicomicosis/microbiología , Onicomicosis/patología , Infecciones Oportunistas/tratamiento farmacológico , Infecciones Oportunistas/inmunología , Infecciones Oportunistas/microbiología , Infecciones Oportunistas/patología , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Factores de Riesgo
11.
J Clin Microbiol ; 40(2): 359-65, 2002 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11825942

RESUMEN

The 87-kDa antigen derived from the fungal pathogen Paracoccidioides brasiliensis can be detected in the sera of infected patients, and its levels have been shown to correlate well with response to treatment and with clinical cure. Despite its potential importance, the antigen has been poorly characterized. The 87-kDa antigen was purified to homogeneity via preparative gel electrophoresis; N-terminal amino acid sequencing revealed substantial homology with heat shock proteins (hsps) from a variety of organisms. A monoclonal antibody (MAb) raised against a Histoplasma capsulatum 80-kDa hsp showed cross-reactivity to the purified 87-kDa antigen via Western blotting, and the 87-kDa-specific MAb P1B demonstrated that the antigen was expressed at higher levels in yeast than in mycelia by the same technique. Enzyme-linked immunosorbent assay and immunofluorescence reactivity using P1B confirmed increased expression of the 87-kDa antigen during the temperature-induced transformation of mycelia to yeast. Yeast-to-mycelium transformation was accompanied by a fall in expression, although the 87-kDa antigen was clearly constitutively expressed in both phases. Immunochemical staining of tissues from patients with MAb P1B who were infected with P. brasiliensis confirmed in vivo expression of the 87-kDa antigen by yeasts, and identification of this antigen via this method appears to be a useful adjunct to other methods used to diagnose paracoccidioidomycosis.


Asunto(s)
Antígenos Fúngicos , Proteínas HSP70 de Choque Térmico , Paracoccidioides/inmunología , Paracoccidioidomicosis/diagnóstico , Secuencia de Aminoácidos , Antígenos Fúngicos/análisis , Antígenos Fúngicos/química , Antígenos Fúngicos/aislamiento & purificación , Biopsia , Western Blotting , Proteínas HSP70 de Choque Térmico/análisis , Proteínas HSP70 de Choque Térmico/química , Proteínas HSP70 de Choque Térmico/inmunología , Proteínas HSP70 de Choque Térmico/aislamiento & purificación , Humanos , Inmunohistoquímica , Datos de Secuencia Molecular , Paracoccidioides/crecimiento & desarrollo , Paracoccidioidomicosis/microbiología
12.
J Clin Microbiol ; 41(4): 1536-42, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12682142

RESUMEN

The diagnosis of paracoccidioidomycosis (PCM) has relied on the identification of the host's humoral response by using a variety of immunological methods, such as complement fixation and immunodiffusion. Although these approaches are useful, historically their sensitivity and specificity have often been compromised by the use of complex mixtures of undefined antigens. The use of combinations of purified, well-characterized antigens appears preferable and may yield optimum results. Accordingly an indirect enzyme-linked immunosorbent assay (ELISA) using combinations of the previously described 27-kDa recombinant antigen and the 87-kDa heat shock protein were used for diagnosis and follow-up of patients with PCM. A total of 37 patients classified according to their clinical presentations (7 with the acute or subacute form of the disease, 22 with the chronic form of the disease, and 8 with the chronic unifocal form) were studied. Eighteen of these patients were also evaluated at every follow-up appointment. Forty serum samples from patients with other diseases and 50 serum samples from healthy individuals were also studied. Detection of anti-27-kDa and anti-87-kDa antibodies in sera of patients with PCM by ELISA using a combination of the two purified proteins showed a sensitivity of 92% with a specificity of 88% in comparison with normal human sera and 90% in comparison with the heterologous sera. These results demonstrated a significant increase in sensitivity and specificity compared to results when the antigens were used separately. Thus, the use of combinations of well-defined antigens appears to offer clear advantages over the use of single antigens when diagnosing PCM.


Asunto(s)
Anticuerpos Antifúngicos/sangre , Antígenos Fúngicos/inmunología , Paracoccidioides/inmunología , Paracoccidioidomicosis/diagnóstico , Proteínas Recombinantes/inmunología , Antígenos Fúngicos/genética , Ensayo de Inmunoadsorción Enzimática , Humanos , Paracoccidioides/genética , Paracoccidioidomicosis/microbiología , Valor Predictivo de las Pruebas , Sensibilidad y Especificidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA